Compare TWST & MOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWST | MOH |
|---|---|---|
| Founded | 2013 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 10.5B |
| IPO Year | 2018 | 2002 |
| Metric | TWST | MOH |
|---|---|---|
| Price | $127.34 | $203.26 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 13 |
| Target Price | $46.88 | ★ $167.00 |
| AVG Volume (30 Days) | ★ 1.7M | 475.5K |
| Earning Date | 05-04-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.89 | N/A |
| EPS | N/A | ★ 1.46 |
| Revenue | $376,572,000.00 | ★ $45,426,000,000.00 |
| Revenue This Year | $18.91 | $2.40 |
| Revenue Next Year | $15.07 | $5.18 |
| P/E Ratio | ★ N/A | $139.10 |
| Revenue Growth | ★ 20.32 | 11.75 |
| 52 Week Low | $23.30 | $121.06 |
| 52 Week High | $155.44 | $244.89 |
| Indicator | TWST | MOH |
|---|---|---|
| Relative Strength Index (RSI) | 56.63 | 53.05 |
| Support Level | $39.81 | $188.66 |
| Resistance Level | N/A | $214.83 |
| Average True Range (ATR) | 8.97 | 6.29 |
| MACD | -1.40 | 0.83 |
| Stochastic Oscillator | 53.31 | 48.17 |
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.